TickerLeague

Revenue for Moderna (MRNA)

According to Moderna's latest reported financial statements, the company's current revenue (TTM) is $1.94B USD. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings (not a live revenue-per-second estimate).

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

TTM (last 4 quarters)

$1.94B

YoY change

-39.2%

5Y CAGR

+19.3%

Peak year (2022)

$18.88B

Cumulative revenue

$49.91B

Revenue history chart for Moderna (MRNA) from 2016 to 2025

Revenue history table for Moderna (MRNA) from 2016 to 2025

Fiscal yearPeriod endedReportedRevenueYoY
2025$1.94B-39.2%
2024$3.20B-53.3%
2023$6.85B-63.7%
2022$18.88B+6.4%
2021$17.74B+2107.6%
2020$803.39M+1234.3%
2019$60.21M-55.4%
2018$135.07M-34.4%
2017$205.82M+89.9%
2016$108.40M

Revenue values are taken from Moderna's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

2025's annual revenue for Moderna (MRNA) came in at $1.94B – plunged 39.2% year-over-year.

Over 2020–2025 (5 years), Moderna revenue expanded at a +19.3% compound annual rate, with the latest reading among the more recent periods of the dataset.

Moderna revenue plunged from $18.88B in 2022 to $1.94B in 2025, a 89.7% drawdown.

2022 marks the peak revenue at $18.88B, with the historical low of $60.21M recorded in 2019.

Among 8 Healthcare peers, Moderna (MRNA) ranks 9th; the peer median for revenue is $65.09B.

Moderna Revenue by Year

Moderna Revenue 2025: $1.94B

Moderna revenue in 2025 was $1.94B, plunged 39.2% below 2024.

Moderna Revenue 2024: $3.20B

Moderna revenue in 2024 was $3.20B, plunged 53.3% below 2023.

Moderna Revenue 2023: $6.85B

Moderna revenue in 2023 was $6.85B, plunged 63.7% below 2022.

Moderna Revenue 2022: $18.88B

Moderna revenue in 2022 was $18.88B, grew 6.4% from 2021. This figure represents the highest annual value in the available history.

Moderna Revenue 2021: $17.74B

Moderna revenue in 2021 was $17.74B.

See more financial history for Moderna (MRNA).

Sector peers — Revenue

Companies in the same sector as Moderna, ranked by their latest revenue.

CompanyRevenueSector
UnitedHealth Group Incorporated (UNH)$447.57BHealthcare
Novo Nordisk A/S (NVO)$309.06BHealthcare
Johnson & Johnson (JNJ)$94.19BHealthcare
Eli Lilly and Company (LLY)$65.18BHealthcare
Merck & Co., Inc. (MRK)$65.01BHealthcare
AbbVie Inc. (ABBV)$61.16BHealthcare
AstraZeneca PLC (AZN)$58.74BHealthcare
Amgen Inc. (AMGN)$36.74BHealthcare

Frequently asked questions

What is Moderna's revenue?

Latest reported revenue for Moderna (MRNA) is $1.94B (period ending December 31, 2025).

How has Moderna revenue changed year-over-year?

Moderna (MRNA) revenue changed -39.2% year-over-year on the latest annual filing.

What is the long-term growth rate of Moderna revenue?

Moderna (MRNA) revenue compound annual growth rate is +19.3% over the most recent 5 years available.

When did Moderna revenue hit its highest annual value?

Moderna revenue reached its highest annual value of $18.88B in 2022.

What was Moderna revenue in 2024?

Moderna (MRNA) revenue in 2024 was $3.20B.

What was Moderna revenue in 2025?

Moderna (MRNA) revenue in 2025 was $1.94B.

Metrics overview

Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.